If you use kratom and you're thinking about quitting — or you're facing a workplace drug test and trying to understand your situation — the question of how long kratom stays in your system is practical, not abstract. The answer depends on several factors, and the misinformation on this topic is significant.
TL;DR: Mitragynine, kratom's primary alkaloid, has a half-life of roughly 9–24 hours in most users. Full urinary clearance typically takes 5–9 days for moderate daily users; heavy or extract-based use extends this. Standard 5-panel urine drug screens do not test for mitragynine — they test for opioids, and kratom generally does not trigger these. Specialized and extended panels CAN detect mitragynine and are increasingly used by some employers and the military. Clearance timing also maps onto withdrawal: the faster-clearing 7-hydroxymitragynine drives the early acute withdrawal peak.
How kratom clears from the body
Mitragynine — the primary alkaloid in kratom leaf by volume — is metabolized primarily in the liver via cytochrome P450 enzymes (particularly CYP3A4 and CYP2D6). Its half-life has been measured in pharmacokinetic studies at approximately 9–24 hours in most subjects, with some studies centering around 9.4 hours in single-dose models.
Half-life is the time it takes for the concentration in blood to fall by half. For complete elimination, the standard estimate is 5–6 half-lives. At a 9-hour half-life, mitragynine would theoretically clear blood in roughly 2–3 days. In practice, urinary clearance — which is what drug tests measure — takes longer: 5–9 days for moderate daily users, based on urinalysis studies (Basiliere & Kerrigan, 2019).
7-hydroxymitragynine (7-OH) — the active metabolite that binds opioid receptors more potently than mitragynine — has a shorter half-life, clearing faster than its parent compound. This creates an important asymmetry: 7-OH clears first, while mitragynine lingers longer. For people using extract-heavy products (which have higher mitragynine-to-7-OH ratios), this affects both detection windows and early withdrawal intensity.
Other kratom alkaloids (speciociliatine, paynantheine, corynantheidine) are present in smaller quantities and clear on similar or faster timelines. They are not tested for on standard drug screens.
What drug tests actually look for
This is where most of the confusion lives.
Standard 5-panel urine drug screen: Tests for cannabis (THC), cocaine (benzoylecgonine), amphetamines, opiates (morphine, codeine), and phencyclidine (PCP). Kratom alkaloids are not on this panel. Mitragynine does not typically trigger a false positive for opiates on standard immunoassay tests because the cross-reactivity between mitragynine and opiate immunoassay antibodies is low.
Standard 10-panel screen: Extends to add barbiturates, benzodiazepines, methadone, propoxyphene, methaqualone, and sometimes tramadol. Still does not include kratom.
Extended opioid panels and kratom-specific panels: Some laboratory tests — used by certain employers, federal agencies, and the military — now include mitragynine and/or 7-OH specifically. Liquid chromatography–mass spectrometry (LC-MS/MS) and gas chromatography–mass spectrometry (GC-MS) can reliably detect and quantify mitragynine in urine. If your employer or contractor uses these panels, kratom use will be detected.
Hair follicle tests: Kratom alkaloids are theoretically detectable in hair for longer windows (potentially 90 days), but hair follicle testing for mitragynine is not standard and is rarely used in employment screening.
Practical implication by situation:
| Screening context | Likely to detect kratom? | |---|---| | Standard pre-employment 5-panel | No | | Standard 10-panel | No | | Military / federal contractor testing | Increasingly yes — panels vary | | DOT (transportation workers) | No — currently | | Employer with expanded panel | Depends on panel — ask the lab |
If you're uncertain about what your employer tests for, the safest approach is to request a panel specification from HR or the testing lab. "What does this panel test for?" is a legitimate question with a specific answer.
What extends the clearance window
The 5–9 day estimate for typical users assumes moderate daily use of plain leaf kratom. Several factors push the window longer:
Dose. Higher doses mean more alkaloid in the body to clear. A user at 15–20 grams daily will take longer to clear than a user at 4–6 grams daily, even with the same half-life kinetics, because the volume of drug to eliminate is larger.
Duration of use. Kratom alkaloids distribute into tissues over time with chronic use. Tissue-stored alkaloids re-enter the bloodstream as clearance occurs, extending the detection window beyond what single-dose pharmacokinetics would predict. Long-term heavy users may see detection windows of 9–14 days or longer.
Extract-based use. Kratom extracts concentrate alkaloids — a "10x extract" product contains approximately 10 times the alkaloid load of equivalent plain leaf by weight. Higher alkaloid concentration per dose means more to clear. Users who have shifted from plain leaf to extracts typically clear more slowly than the standard estimates.
Individual metabolism. CYP3A4 activity varies between individuals — genetic variation, medication interactions (certain drugs inhibit CYP3A4, slowing kratom clearance), liver function, age, and body composition all affect clearance rate. Slower metabolizers take longer.
Hydration and kidney function. Urinary excretion is the primary clearance route. Adequate hydration supports normal clearance rates; dehydration or impaired renal function slows it.
What clearance timing means for withdrawal
This connection is underappreciated, and it's worth understanding if you're planning cessation.
Kratom withdrawal onset timing correlates with clearance: for daily users stopping abruptly, acute withdrawal symptoms typically begin 12–24 hours after the last dose and peak within 2–4 days. This timeline tracks with mitragynine's 9–24 hour half-life — as blood concentrations fall below the threshold that keeps receptors occupied, withdrawal begins.
The 7-OH asymmetry matters here. Because 7-OH has a shorter half-life than mitragynine and clears first, users with high 7-OH exposure — primarily those using extract products — often experience a more front-loaded early withdrawal. The 7-OH-driven opioid receptor effects drop off faster, producing an early acute phase that can be more intense than plain-leaf users experience.
For people using moderate plain leaf doses, the longer mitragynine half-life means a slightly more gradual onset — withdrawal may not peak until days 2–3. This is a clinical nuance, not a meaningful difference in outcome, but it helps explain why some users' accounts of timing don't match others'.
Clearance and post-acute withdrawal: Full clearance of kratom alkaloids from the body does not mean the withdrawal is over. Post-acute withdrawal syndrome (PAWS) — the neurological recalibration phase involving mood, sleep, and energy — continues for weeks to months after the substances clear. Alkaloid-free does not mean neurologically stable. See our piece on kratom PAWS for the full picture.
Planning around a drug test
If you are facing an employment drug screen and you use kratom daily, the relevant questions are:
-
Does this panel test for mitragynine? Ask explicitly. If it's a standard 5 or 10-panel, you're unlikely to be detected. If it's a military, federal contractor, or expanded panel, assume it may include kratom.
-
When does the test occur? For standard-panel tests, timing is irrelevant (kratom isn't tested). For extended panels, you need the clearance window — 7–14 days for most users, potentially longer for extract-based or very heavy use.
-
Can you stop in time? If cessation is the plan anyway, clearance timing may be a motivation factor. For people at the contemplation stage, the practical reality of detection can be a concrete reason to start a taper now rather than later.
What doesn't work: excessive water intake to dilute urine (flagged on drug tests and doesn't meaningfully accelerate clearance), detox products (no evidence of efficacy for kratom specifically), or short windows of abstinence before a test (the clearance window is what it is).
Getting support for cessation
If you're planning to stop kratom and want clinical support — either for managing withdrawal or navigating the timeline — findtreatment.gov (SAMHSA's treatment locator) lists addiction medicine providers by location. Telehealth options are available and often faster to access than in-person.
Our existing piece on kratom withdrawal timeline covers what to expect day by day. For high-dose or extract-based users, our article on kratom leaf vs. extract vs. 7-OH explains why the clearance and withdrawal profiles differ.
Coach Aria is a 12-week behavioral coaching program for kratom recovery. Private, app-based, runs at your pace. Built specifically for how kratom's pharmacology works — not borrowed from an opioid or stimulant track.